News in brief: Precision oncology studies lack diversity; Rudd backs oncology trial collaboration to stop cold war; One in four patients wait too long for essential procedures

Precision oncology studies lacking in diversity Precision oncology studies for breast, lung, prostate, and colorectal cancers underrepresent racial and ethnic minority populations relative to their cancer incidence in the population, a US study has shown. Analysis of 93 studies involving 5867 cancer patients found that participants were predominantly white, whereas Black participants were significantly underrepresented ...

Already a member?

Login to keep reading.

© 2022 the limbic